Genomic Characterization and Safety Assessment of Bifidobacterium breve BS2-PB3 as Functional Food

키워드

참고문헌 (60)

1. Kandasamy S, "Probiogenomic in-silico analysis and safety assessment of Lactiplantibacillus plantarum DJF10 strain isolated from Korean raw milk", Int. J. Mol. Sci, 23, pp.14494~ (2022)
2. Report of a joint FAO, "WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria", FAO, 2001
3. Reuter G, "The Lactobacillus and Bifidobacterium microflora of the human intestine : composition and succession", Curr. Issues Intest. Microbiol, 2, pp.43~53 (2001)
4. Latif A, "Probiotics : mechanism of action, health benefits and their application in food industries", Front. Microbiol, 14, pp.1216674~ (2023)
5. Chen J, "Recent development of probiotic Bifidobacteria for treating human diseases", Front. Bioeng. Biotechnol, 9, pp.770248~ (2021)
6. Bozzi Cionci N, "Therapeutic microbiology : the role of Bifidobacterium breve as food supplement for the prevention", treatment of paediatric diseases, 2018, pp.10, 1723~
7. Thibault H, "Effects of long-term consumption of a fermented infant formula(with Bifidobacterium breve c50 and Streptococcus thermophilus 065)on acute diarrhea in healthy infants", J. Pediatr. Gastroenterol. Nutr, 39, pp.147~152 (2004)
8. Wong CB, "Exploring the science behind Bifidobacterium breve M-16V in infant health", Nutrients, 11, pp.1724~ (2019)
9. Choi IY, "Safety evaluation of Bifidobacterium breve IDCC4401 isolated from infant feces for use as a commercial probiotic", J. Microbiol. Biotechnol, 31, pp.949~955 (2021)
10. Shori AB, "Application of Bifidobacterium spp. In beverages and dairy food products: an overview of survival during refrigerated storage", Food Sci. Technol, 42, pp.e41520~ (2022)
11. Linares DM, "Lactic acid bacteria and Bifidobacteria with potential to design natural biofunctional health-promoting dairy foods", Front. Microbiol, 8, pp.846~ (2017)
12. Xiao J, "Probiotic Bifidobacterium breve in improving cognitive functions of older adults with suspected mild cognitive impairment : a randomized, double-blind, placebo-controlled trial", J. Alzheimers Dis, 77, pp.139~147 (2020)
13. Minami J, "Oral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trial", J. Nutr. Sci, 4, pp.E17~ (2015)
14. Umborowati MA, "The role of probiotics in the treatment of adult atopic dermatitis : a meta-analysis of randomized controlled trials", J. Health Popul. Nutr, 41, pp.37~ (2022)
15. Sanders ME, "Safety assessment of probiotics for human use", Gut Microbes, 1, pp.164~185 (2010)
16. Gueimonde M, "Antibiotic resistance in probiotic bacteria", Front. Microbiol, 4, pp.202~ (2013)
17. Kolmogorov M, "Assembly of long, error-prone reads using repeat graphs", Nat. Biotechnol, 37, pp.540~546 (2019)
18. Tanizawa Y, "DFAST : a flexible prokaryotic genome annotation pipeline for faster genome publication", Bioinformatics, 34, pp.1037~1039 (2018)
19. Grant JR, "Proksee: in-depth characterization and visualization of bacterial genomes", Nucleic Acids Res, 51, pp.W484~W492 (2023)
20. Chen L, "VFDB : a reference database for bacterial virulence factors", Nucleic Acids Res, 33, pp.325~328 (2005)
21. Siguier P, "ISfinder : the reference centre for bacterial insertion sequences", Nucleic Acids Res, 34, pp.D32~D36 (2006)
22. McArthur AG, "The comprehensive antibiotic resistance database", Antimicrob. Agents Chemother, 58, pp.212~220 (2013)
23. Jorgensen JH, "Manual of clinical microbiology", pp.1253~1273 (2015), American Society of Microbiology
24. Latorre-Pérez A, "Assembly methods for nanopore-based metagenomic sequencing : a comparative study", Sci. Rep, 10, pp.13588~ (2020)
25. Pfeiffer F, "Systematic evaluation of error rates and causes in short samples in next-generation sequencing", Sci. Rep, 8, pp.10950~ (2018)
26. Valdez-Baez J, "Comparative genomics and in silico evaluation of genes related to the probiotic potential of Bifidobacterium breve 1101A", Bacteria, 1, pp.161~182 (2022)
27. Rodrigo-Torres L, "Genome sequence of Bifidobacterium breve INIA P734(CECT 8178), a strain isolated from human breast milk", Microbiol. Resour. Announc, 10, pp.e00871-20~ (2021)
28. Parlindungan E, "Lactic acid bacteria diversity and characterization of probiotic candidates in fermented meats", Foods, 10, pp.1519~ (2021)
29. Aakko J, "Assessment of stress tolerance acquisition in the heat-tolerant derivative strains of Bifidobacterium animalis subsp. lactis BB-12 and Lactobacillus rhamnosus GG", J. Appl. Microbiol, 117, pp.239~248 (2014)
30. Schöpping M, "Stress response in bifidobacteria", Microbiol. Mol. Biol. Rev, 86, pp.e0017021~ (2022)
31. Xu Q, "The MarR family regulator BmrR is involved in bile tolerance of Bifidobacterium longum BBMN68 via controlling the expression of an ABC transporter", Appl. Environ. Microbiol, 85, pp.e02453-18~ (2019)
32. Ouwehand AC, "The effect of digestive enzymes on the adhesion of probiotic bacteria in vitro", J. Food Sci, 66, pp.856~859 (2001)
33. Zhang J, "The complete genome sequence of Bifidobacterium animalis subsp. lactis 01 and its integral components of antioxidant defense system", 3 Biotech, 9, pp.352~ (2019)
34. Lee C, "Exploring probiotic effector molecules and their mode of action in gut-immune interactions", FEMS Microbiol. Rev, 47, pp.fuad046~ (2023)
35. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, "Clinically and laboratory standards institute", ~, pp.CLSI document M07-A9 (2012)
36. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), "Guidance on the assessment of bacterial susceptibility to antimicrobials of human and veterinary importance", EFSA J, 10, pp.2740~ (2012)
37. Turroni F, "Exploring the diversity of the bifidobacterial population in the human intestinal tract", Appl. Environ. Microbiol, 75, pp.1534~1545 (2009)
38. Serafini F, "Insights into physiological and genetic mupirocin susceptibility in bifidobacteria", Appl. Environ. Microbiol, 77, pp.3141~3146 (2011)
39. Taft DH, "Bifidobacterial dominance of the gut in early life and acquisition of antimicrobial resistance", mSphere, 3, pp.e00441-18~ (2018)
40. Ammor MS, "Antibiotic resistance in non-enterococcal lactic acid bacteria and bifidobacteria", Food Microbiol, 24, pp.559~570 (2007)
41. Moubareck C, "Antimicrobial susceptibility of bifidobacteria", J. Antimicrob. Chemother, 5, pp.38~44 (2005)
42. Masco L, "Antimicrobial susceptibility of Bifidobacterium strains from humans, animals and probiotic products", J. Antimicrob. Chemother, 58, pp.85~94 (2006)
43. Kim M J, "Safety evaluations of Bifidobacterium bifidum BGN4 and Bifidobacterium longum BORI", Int. J. Mol. Sci, 19, pp.1422~ (2018)
44. Mancino W, "Mobilome and resistome reconstruction from genomes belonging to members of the Bifidobacterium genus", Microorganisms, 7, pp.638~ (2019)
45. Tsuchida S, "Genomic characteristics of Bifidobacterium thermacidophilum pig isolates and wild boar isolates reveal the unique presence of a putative mobile genetic element with tetW for pig farm", Front. Microbiol, 8, pp.1540~ (2017)
46. Cho H, "Beta-lactam antibiotics induce a lethal malfunctioning of the bacterial cell wall synthesis machinery", Cell, 159, pp.1300~1311 (2014)
47. Paterson GK, "The emergence of mecC methicillin-resistant Staphylococcus aureus", Trends Microbiol, 22, pp.42~47 (2014)
48. Ricci V, "RamA, which controls expression of the MDR efflux pump AcrAB-TolC, is regulated by the Lon protease", J. Antimicrob. Chemother, 69, pp.643~650 (2014)
49. Levy C, "Dihydropteroate synthase from Streptococcus pneumoniae : structure, ligand recognition and mechanism of sulfonamide resistance", Biochem. J, 412, pp.379~388 (2008)
50. Razavi M, "Discovery of the fourth mobile sulfonamide resistance gene", Microbiome, 5, pp.160~ (2017)
51. Seah C, "MupB, a new high-level mupirocin resistance mechanism in Staphylococcus aureus", Antimicrob. Agents Chemother, 56, pp.1916~1920 (2012)
52. Hurdle JG, "Analysis of mupirocin resistance and fitness in Staphylococcus aureus by molecular genetic and structural modeling techniques", Antimicrob. Agents Chemother, 48, pp.4366~4376 (2004)
53. Abdulgader SM, "The prevalence and molecular mechanisms of mupirocin resistance in Staphylococcus aureus isolates from a hospital in Cape Town, South Africa", Antimicrob. Resist. Infect. Control, 9, pp.47~ (2020)
54. Hetem D J, "Clinical relevance of mupirocin resistance in Staphylococcus aureus", J. Hosp. Infect, 85, pp.249~256 (2013)
55. Charteris WP, "Antibiotic susceptibility of potentially probiotic Lactobacillus species", J. Food Prot, 61, pp.1636~1643 (1998)
56. Aditi FY, "A study on the microbiological status of mineral drinking water", Open Microbiol. J, 11, pp.31~44 (2017)
57. Chukiatsiri K, "Serovar identification, antimicrobial sensitivity, and virulence of Avibacterium paragallinarum isolated from chickens in Thailand", Avian. Dis, 56, pp.359~364 (2012)
58. Patel JB, "Mupirocin resistance", Clin. Infect. Dis, 49, pp.935~941 (2009)
59. Performance standards for antimicrobial susceptibility testing; twentyfourth informational supplement, "Clinical and Laboratory Standards Institute (CLSI)", Clinical and Laboratory Standards Institute, ~, pp.CLSI document M100-S24 (2014)
60. Rajkumari N, "Resistance pattern of mupirocin in methicillinresistant Staphylococcus aureus in trauma patients and comparison between disc diffusion and E-test for better detection of resistance in low resource countries", J. Lab. Phyicians, 6, pp.91~95 (2014)

관련 논문AI추천